TomoTherapy extends French connection

Article

Other headlines:Epix shakes up business leadership

TomoTherapy extends French connection

Centre Oscar Lambret in Lille, France, has begun treating cancer patients with the TomoTherapy Hi•Art treatment system, which uses CT to guide radiotherapy. Centre Oscar Lambret has ordered two such systems. The second is scheduled for installation later this year. Five other centers in France have adopted TomoTherapy's advanced cancer treatment technology: Institut Curie in Paris, Institut Bergonié in Bordeaux, Centre Paul Strauss in Strasbourg, Centre René Gauducheau in Saint Herblain, and Institut Claudius Regaud in Toulouse. Their embrace of the product comes in the wake of a July 2005 call for research proposals launched by the Institut National du Cancer to promote implementation of image-guided radiotherapy.

Epix shakes up business leadership

Chen Schor has resigned as chief business officer of Epix Pharmaceuticals. The company's former head of business development and current vice president of discovery and manufacturing, Sheila DeWitt, Ph.D., will lead the company's business development efforts, according to Epix. Schor became chief business officer in August 2006 following the company's merger with Predix. He was one of the lead investors in Predix Pharmaceuticals when the company incorporated in 2000. Schor will leave Epix effective March 23. His replacement has led efforts to reacquire worldwide rights to the Epix blood-pool MR contrast agent, Vasovist, following the decision of the company to pursue therapeutic agents in the Predix pipeline. DeWitt has also worked on arrangements to monetize rights to Vasovist, following its FDA approval.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.